Mortality factors in recurrent parathyroid cancer: a pooled analysis

被引:8
作者
Tsai, Wen-Hsuan [1 ]
Zeng, Yi-Hong [1 ,2 ]
Lee, Chun-Chuan [1 ,2 ]
Tsai, Ming-Chieh [1 ,2 ]
机构
[1] Mackay Mem Hosp, Dept Endocrinol, Dept Internal Med, Div Endocrinol & Metab, 92,Sec 2,Zhongshan N Rd, Taipei 104, Taiwan
[2] MacKay Med Coll, Dept Med, New Taipei, Taiwan
关键词
Parathyroid cancer; Recurrence; Bone metastasis; Prognostic factor; PULMONARY METASTASES; TELOMERASE ACTIVITY; PROGNOSTIC-FACTORS; CARCINOMA; DIAGNOSIS; HYPERCALCEMIA; MANAGEMENT; PATIENT; PARAFIBROMIN; SURGERY;
D O I
10.1007/s00774-021-01305-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Parathyroid cancer is a rare disease with high recurrence rate. The prognostic factors for recurrent parathyroid cancer are yet to be ascertained. We aimed to establish the association between recurrent parathyroid cancer and previously reported prognostic factors. Materials and methods We conducted a PubMed search using the keywords 'parathyroid cancer', 'parathyroid neoplasm', and 'hypercalcemia' during 1966-2019 and included 3272 articles. We focused on 73 patients with recurrent parathyroid cancer from 55 studies. We conducted a survival analysis using the Cox proportional hazards model with 95% confidence interval. Results For the 73 patients included in the analysis, the mean age (+/- standard deviation) was 44 +/- 13.2 years, wherein 36 patients were women (49.3%). During the 5236 person-months at risk (mean follow-up 71.7 months, range 3-264), 38 patients died. The incidence of local recurrence, lymph-node metastasis, lung metastasis, and bone metastasis were 60.3, 12.3, 56.2, and 24.7, respectively. Bone metastasis, disease-free interval < 1 year, and total surgeries < 3 were significant prognostic factors in univariate analysis (log-rank test P = 0.0063, P = 0.0006, and P = 0.0056, respectively). In the multivariate-adjusted analysis, the mortality risk was significantly increased in patients with bone metastasis with a hazard ratio (HR) of 4.83 (95% CI 1.16-20.2; P = 0.03), disease-free interval <=1 year of 5.92 (95% CI 1.85-18.99; P = 0.003), and total surgeries <3 of 11.29 (95% CI 2.82-45.22; P = 0.001), considering these as possible predictive prognostic factors. Conclusion Bone metastasis, duration of disease-free interval, and total number of surgeries predict survival in recurrent parathyroid cancer.
引用
收藏
页码:508 / 517
页数:10
相关论文
共 50 条
  • [21] Mediastinal Parathyroid Cancer
    Schulte, Klaus-Martin
    Galata, Gabriele
    Talat, Nadia
    CANCERS, 2022, 14 (23)
  • [22] Factors predicting recurrent endometrial cancer
    Huijgens, A. N. J.
    Mertens, H. J. M. M.
    FACTS VIEWS AND VISION IN OBGYN, 2013, 5 (03) : 179 - 186
  • [23] Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer
    Christakis, Ioannis
    Bussaidy, Naifa
    Clarke, Callisia
    Kwatampora, Lily Joy
    Warneke, Carla L.
    Silva, Angelica M.
    Williams, Michelle D.
    Grubbs, Elizabeth Gardner
    Lee, Jeffrey E.
    Perrier, Nancy D.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (09) : 2889 - 2897
  • [24] Lymph Node Involvement and Surgical Approach in Parathyroid Cancer
    Schulte, Klaus-Martin
    Talat, Nadia
    Miell, John
    Moniz, Caje
    Sinha, Prakash
    Diaz-Cano, Salvador
    WORLD JOURNAL OF SURGERY, 2010, 34 (11) : 2611 - 2620
  • [25] Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group
    Canzler, Ulrich
    Lueck, Hans-Joachim
    Neuser, Petra
    Sehouli, Jalid
    Burges, Alexander
    Harter, Philipp
    Schmalfeldt, Barbara
    Aminossadati, Behnaz
    Mahner, Sven
    Kommoss, Stefan
    Wimberger, Pauline
    Pfisterer, Jacobus
    de Gregorio, Nikolaus
    Hasenburg, Annette
    Gropp-Meier, Martina
    El-Balat, Ahmed
    Jackisch, Christian
    du Bois, Andreas
    Meier, Werner
    Wagner, Uwe
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (05) : 1267 - 1274
  • [26] Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: A retrospective study of 108 cases
    Classe, J. M.
    Jaffre, I.
    Frenel, J. S.
    Bordes, V.
    Dejode, M.
    Dravet, F.
    Ferron, G.
    Marchal, F.
    Rigaud, D. Berton
    Loussouarn, D.
    Campion, L.
    EJSO, 2011, 37 (11): : 971 - 977
  • [27] Multivariate survival analysis of the patients with recurrent endometrial cancer
    Odagiri, Tetsuji
    Watari, Hidemichi
    Hosaka, Masayoshi
    Mitamura, Takashi
    Konno, Yousuke
    Kato, Tatsuya
    Kobayashi, Noriko
    Sudo, Satoko
    Takeda, Mahito
    Kaneuchi, Masanori
    Sakuragi, Noriaki
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (01) : 3 - 8
  • [28] Surgical resection of recurrent colonic cancer
    Harji, D. P.
    Sagar, P. M.
    Boyle, K.
    Griffiths, B.
    McArthur, D. R.
    Evans, M.
    BRITISH JOURNAL OF SURGERY, 2013, 100 (07) : 950 - 958
  • [29] Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
    R Y Zang
    P Harter
    D S Chi
    J Sehouli
    R Jiang
    C G Tropé
    A Ayhan
    G Cormio
    Y Xing
    K M Wollschlaeger
    E I Braicu
    C A Rabbitt
    H Oksefjell
    W J Tian
    C Fotopoulou
    J Pfisterer
    A du Bois
    J S Berek
    British Journal of Cancer, 2011, 105 : 890 - 896
  • [30] Factors influencing cost, length of hospital stay and mortality in colorectal cancer
    Bilgin, Bulent Caglar
    Kahramanca, Sahin
    Akin, Tezen
    Gokce, Ismail Emre
    Akin, Merve
    Kucukpinar, Tevfik
    JOURNAL OF BUON, 2015, 20 (04): : 1023 - 1029